Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial - SCMP
Direct Source Verification:
This story is aggregated from South China Morning Post (scmp.com). Full reporting rights and copyright belong to the primary publisher.
Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial SCMP
Original Source
https://news.google.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?oc=5
